1Socinski MA, Bogart JA. Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol, 2007, 25:4137 -4145.
2Wan L, Hyo-Im C, Mi-Jin K, et al. Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability. Exp. Mol. Meal,2008,40( 1 ) :109 - 117.
5Orky AR, Stehfest E, Viehweger K, et al. Immuno-histoehemical detection of MRPs in human lung cells in culture. Toxicology, 2005,207 (3) :437 - 450.
6Benlloch M, Ortega A, Ferrer P. Acceleration of glutathione efflux and inhibition of gamma glutamyltranspep tidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity. Journal of Biological Chemistry, 2005,280 ( 8 ) : 6950 - 6959.
7Brooks T, Minderman H, Kieran L, et al. Taxane-based reversal agents modulate drug resistance mediated by P-glycop retein, multidrug resistance protein, and breast cancer resistance protein. Cancer Ther,2003,2 : 1195.
8Rybarova S, Hajdukova M, Hodorova I, et al. Expression of the multidrug resistance-associated protein1 ( MRP1 ) and the lung resistance- related protein (LRP) in human lung cancer. Neop lasma, 2004,51 ( 3 ) : 169 - 174.
9Volm M, Mattern J, Samsel B, et al. Over expression of P-glyco-protein and guhathion S-transrerase-πin resistant non-small cell lung carcionomas of smokers. Br J Cancer,1991,6(4) :700. (GST).
3VOLM M, MATTERN J, SAMSEL B. Overexpression of P-glycoprotein and gultathion S-transrerase-л in resistant non-small cell lung carcionomas of smokers[J]. Br J Cancer, 1991, 6(4): 700.
4ABE S, KUBOTA T, MATSUZAKI SW, et al. Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage Ⅲ non-scirrhous and scirrhous gastric cancers[J]. Anticancer Res, 1999, 19(5C): 4581-4586.
5CARMICHAEL J, MITCHE II JB,DEGRAFF G. Chemosen sitivity testing of human lung cancer cell lines using the MTT assay[J]. Br J Cancer, 1998, 57(6): 540.
6JAIN V, DAS SN, LUTHRA K, et al. Differential expression of multidrug resistance gene product, P-glycoprotein, in normanal,dysplastic and malignant oral mucosa in India[J]. Int J Cancer,1997, 74: 128-133.
7GERMANN UA. P-glycoprotein:a mediator of multidrug resistance in tumor cells[J]. Eur J Cancer, 1996, 32A: 927-944.
8LAI SL, GOLDSTEIN LJ, GOTTESMAN MM, et al. MDR1 gene expression in lung cancer[J]. J Natl Cancer Inst, 1989, 81(15):1144-1150.
9BREUNINGER LM,PAUL S,GAUGHAN K,et al.Overexpression of multidrug resistance-associated protein(MRP) increase resistance to natural product drugs[J].Cancer Res,1994,54:357-361.
10Morimoto E,Inase N,Mlyake S,et al.Adenovirusmediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter[J]. Anticancer Res,2001,21(2):329-332.
3Szabo D, Keyzer H, Kaiser HE, et al. Reversal of mul -tidrug resistance of tumor cells [ J] ? Anticancer Res,2000,20 (6B) :4261 -4274.
4Xie X,Dwyer MD,Swenson L,et al. Crystal structure of cal-cium -free human sorcin : a member of the penta - EF -hand protein family[ J]. Protein Sci,2001,10( 12) :2419 -2425.
5Meyers MB. Sorcin: a calcium - binding protein overpro-duced in many multidrug—resistant cells [ A ]. Smith V L,Dedman J R. Stimulus response coupling : the role of intra-cellular calcium - binding proteins [ M ] ? Boca Raton : CRCPress, 1990:159 -171.
7Parekh HK, Deng H B, Choudhary K, et al. Overexpres-sion of sorcin,a calcium - binding protein,induces a lowlevel of paclitaxel resistance in human ovarian and breastcancer cell [ J ] . Biochem Pharmacol,2002 , 62 ( 6 ):1149 — 1158.
